Modulation of the K+ Channels Encoded by the Human Ether-a-Gogo-Related Gene-1 (hERG1) by Nitric Oxide

  1. Maurizio Taglialatela,
  2. Anna Pannaccione,
  3. Silvana Iossa,
  4. Pasqualina Castaldo and
  5. Lucio Annunziato
  1. Section of Pharmacology, Department of Neuroscience, School of Medicine, University of Naples Federico II, Naples, Italy

    Abstract

    The inhibition of nitric oxide synthase byN-nitro-l-arginine methyl ester (0.03–3 mM) dose-dependently reduced nitric oxide (NO) levels and enhanced the outward currents carried by human ether-a-gogo-related gene-1 (hERG1) K+ channels expressed inXenopus laevis oocytes, whereas the increase in NO levels achieved by exposure to l-arginine (0.03–10 mM) inhibited these currents. Furthermore, four NOdonors belonging to such different chemical classes as sodium nitroprusside (1–1000 μM), 3-morpholino-sydnonimine (100–1000 μM), (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (NOC-18; 1–300 μM), and S-nitrosoN-acetylpenicillamine (1–300 μM) dose-dependently inhibited hERG1 outward K+ currents. By contrast, the NO donor NOC-18 (0.3 mM) did not affect other cloned K+ channels such as rat neuroblastoma-glioma K+ channel 2, rat delayed rectifier K+ channel 1, bovine ether-a-gogo gene, rat ether-a-gogo-related gene-2, and rat ether-a-gogo-related gene-3. The inhibitory effect of NO donors on hERG1 K+ channels was prevented by the NO scavengers 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide and hemoglobin. The membrane permeable analog of cGMP, 8-bromo-cGMP (1 mM), failed to reproduce the inhibitory action of NO donors onhERG1 outward currents; furthermore, the specific inhibitor of the NO-dependent guanylyl cyclase, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (50 μM), neither interfered with outward hERG1K+ currents nor prevented their inhibition by 0.3 mM NOC-18. Both l-arginine (10 mM) and NOC-18 (0.3 mM) counteracted the stimulatory effect on hERG1 outward currents induced by the radical oxygen species-generating system FeSO4 (25 μM)/ascorbic acid (50 μM; Fe/Asc). Finally,l-arginine (10 mM) and NOC-18 (0.3 mM) inhibited both basal and Fe/Asc (0.1 mM/0.2 mM)-stimulated lipid peroxidation in X. laevis oocytes. Collectively, the present results suggest that NO, both endogenously produced and pharmacologically delivered, may exert in a cGMP-independent way an inhibitory effect onhERG1 outward K+ currents via an interaction with radical oxygen species either generated under resting conditions or triggered by Fe/Asc.

    Footnotes

    • Send reprint requests to: Dr. Maurizio Taglialatela, Section of Pharmacology, Department of Neuroscience, School of Medicine, Via. S. Pansini 5, 80131 Naples, Italy. E-mail:mtaglial{at}unina.it

    • The study was supported by Telethon Grant 1058 (to M.T.); National Research Council (CNR) Grants 97.04512.CT04, 97.01230.PF49, and 98.03149.CT04 (to M.T.) and CNR Grants 95.02857.CT04, 98.01048.CT04, and 98.00062.PF31 (PS Biotecnologie 5%) (to L.A.); MURST 60% and 40% (to L.A.); and grants from the Regione Campania (P.O.P. and Legge 41) (to L.A.).

    • Abbreviations:
      NO
      nitric oxide
      ROS
      radical oxygen species
      RNS
      radical nitrogen species
      O2
      superoxide anion
      ONOO
      peroxynitrite
      rNGK2
      rat neuroblastoma-glioma K+ channel 2
      rDRK1
      rat delayed rectifier K+ channel 1
      bEAG
      bovine ether-a-gogo gene
      rERG2 and rERG3
      rat ether-a-gogo-related gene-2 and -3
      hERG1
      human ether-a-gogo related gene-1
      NO2
      nitrite
      MDA
      malondialdehyde
      NOS
      NO synthase
      L-NAME
      N-nitro-l-arginine methyl ester
      NOC-18
      (Z)-1-[N-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate
      SNAP
      S-nitroso N-acetylpenicillamine
      SNP
      sodium nitroprusside
      SIN-1
      3-morpholino-sydnonimine
      PTIO
      2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide
      Hb
      hemoglobin
      ODQ
      1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
      Fe/Asc
      iron- and ascorbate-containing solution
      • Received July 26, 1999.
      • Accepted September 8, 1999.
    « Previous | Next Article »Table of Contents